Anneke Ten Brinke

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response

Margaret J Leckie, Anneke Ten Brinke, Jamey Khan et al. · The Lancet · 2000 · 1.8K citations

Asthma, Allergy, Allergy Medicine +6

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Geoffrey Chupp, Eric Bradford, Frank C. Albers et al. · The Lancet Respiratory Medicine · 2017 · 571 citations

Asthma, Allergy, Health-related Quality +10

Risk factors of frequent exacerbations in difficult-to-treat asthma

Anneke Ten Brinke, PJ Sterk, A. A. M. Masclee et al. · European Respiratory Journal · 2005 · 489 citations · Full text

Asthma, Epidemiology, Allergy +13

Factors Associated with Persistent Airflow Limitation in Severe Asthma

Anneke Ten Brinke, Aeilko H. Zwinderman, Peter Sterk et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 359 citations

Chronic sinusitis in severe asthma is related to sputum eosinophilia

Anneke Ten Brinke, Diana C. Grootendorst, Judith Th. Schmidt et al. · Journal of Allergy and Clinical Immunology · 2002 · 313 citations · Full text

Asthma, Allergy, Chronic Sinusitis +6